Clinical Trials Sponsored by Sakakibara Heart Institute

Total 4760 results

Sakakibara Heart Institute

Completed

The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC) (SHIP-AC)

Atheroscleroses, Coronary | Atherosclerosis of Artery | Cancers
Sakakibara Heart Institute

Completed

The Sakakibara Health Integrative Profile Cohort Study (SHIP-CS)

Cancer
Sakakibara Heart Institute
CellBank of Japan

Unknown

Japanese OMI Treatment With Kit-positive Cells for Enhanced Regeneration (JOKER)

Chronic Heart Failure | Old Myocardial Infarction

Japan
Sakakibara Heart Institute
Japanese Foundation for Cancer Research

Completed

Pathogenic Mechanisms of Cancer and Cardiovascular Diseases

Cardiovascular Diseases | Cancer | Pathogenesis

Japan
Rabin Medical Center
Sakakibara Heart Institute; Ichinomiya-Nishi Hospital; Gifu Heart Center; Fukuoka... and other collaborators

Active, not recruiting

Japan FFRangio Clinical Outcomes Study

Coronary Artery Disease

Israel
Minneapolis Heart Institute Foundation
Minneapolis Heart Institute; Twin Cities Heart Foundation

Terminated

Radiation Following Percutaneous Balloon Aortic Valvuloplasty to Prevent Restenosis (RADAR)

Aortic Valve Stenosis

United States
Montreal Heart Institute
Ottawa Heart Institute Research Corporation

Completed

LVEF Prediction During ACS Using AI Algorithm Applied on Coronary Angiogram Videos (CathEF)

Acute Coronary Syndrome | Left Ventricular Dysfunction

Canada
InCor Heart Institute

Recruiting

Serum Concentration of Endogenous Estrogens and Sirtuin-1 After Administration of Atorvastatin and Quercetin:

Coronary Artery Disease | Menopause

Brazil
Montreal Heart Institute

Not yet recruiting

Multidisciplinary Approach for High-risk Patients Leading to Early Diagnosis of Canadians With Heart Failure (MAPLE-CHF)

Heart Failure

Canada
InCor Heart Institute

Recruiting

The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers (RE-AGES)

Coronary Artery Disease | Menopause | Endothelial Dysfunction

Brazil
Montreal Heart Institute

Recruiting

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes (COLCOT-T2D)

Cardiovascular Diseases | Diabete Type 2

Canada
Montreal Heart Institute

Recruiting

Home-based Heat Therapy for Type 2 Diabetes

Diabetes Mellitus, Type 2 | Heat Exposure

Canada
German Heart Institute

Recruiting

Validation of a Non-invasive Assessment of Central Venous Oxygen Saturation by Using MRI

Heart Failure

Germany
Montreal Heart Institute

Recruiting

Impact of FDG-PET/CT on Management of Patients With Native Valve Infective Endocarditis (PET-NAVIE)

Infective Endocarditis | Native Valve Endocarditis

Canada
InCor Heart Institute

Recruiting

PREemptive Analgesia With preGABAlin in HEART Surgery (PREGABA-HEART)

Postoperative Pain

Brazil
Montreal Heart Institute

Enrolling by invitation

Cardiac Rehabilitation in Congenital Heart Disease: Effects on Brain and Cognitive Functions (CongeNIRS)

Congenital Heart Disease | Congenital Heart Defects

Canada
Montreal Heart Institute

Completed

Feasibility of Prediabetes Remission in Adults With Coronary Heart Disease (DIABEPIC1)

Prediabetic State | Coronary Heart Disease | Healthy Lifestyle | Remission

Canada
Montreal Heart Institute

Completed

Sauna Bathing to Improve Vascular Health of Adults With Heart Disease

Coronary Artery Disease

Canada
Tabba Heart Institute

Completed

Combination of InnoSEAL Plus TR Band Compared to TR Band Alone

Hematoma | Radial Artery Occlusion

Pakistan
Montreal Heart Institute

Completed

Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation (AFFORD)

Atrial Fibrillation

Canada
German Heart Institute

Unknown

Effect of Prescribed Cardiac Rehabilitation in Patients With Advanced Heart Failure or Ventricular Assist Device

Heart Failure

Germany
Tabba Heart Institute

Unknown

Radiation Dose Reduction Using Advanced Fluoroscopy Options in Coronary Cath Lab

Coronary Artery Disease | Radiation Exposure

Pakistan
Montreal Heart Institute

Withdrawn

Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF (EVOLVE-HF)

Heart Failure | Functional Mitral Regurgitation
Montreal Heart Institute

Completed

Effect of Exercise Training on Left Ventricular Function in Patients Post Myocardial Infarction (EXIT-V)

Myocardial Infarction | Coronary Artery Disease | Heart Failure

Canada
Montreal Heart Institute

Completed

Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (NOVA-SKIN)

Chronic Stable Angina

Canada
Montreal Heart Institute

Completed

Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.

Left Ventricular Function Diastolic Dysfunction | Fluid Responsiveness

Canada
InCor Heart Institute

Unknown

Peripherally Inserted Central Catheter Use for Dobutamine Infusion in Heart Failure Patients (DOBUTAPICC)

Congestive Heart Failure

Brazil
Montreal Heart Institute

Completed

Phase-II Study of the Use of PulmoBind for Molecular Imaging of Pulmonary Hypertension (PB-02)

Pulmonary Hypertension

Canada
Montreal Heart Institute

Completed

Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation

Pulmonary Hypertension | Pulmonary Disease

Canada
InCor Heart Institute

Unknown

Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction

Hypertension | Heart Failure, Diastolic

Brazil
Arizona Heart Institute

Unknown

Clinical Study of Abdominal Aortic Aneurysm Exclusion (TALENT Abdominal) (l)

Abdominal Aortic Aneurysm

United States
Montreal Heart Institute

Recruiting

Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease (CD-IT)

Inflammatory Bowel Diseases | Crohn's Disease

Canada
InCor Heart Institute

Recruiting

Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial (SILENT)

Atrial Fibrillation

Brazil
Montreal Heart Institute

Active, not recruiting

Home-Based Exercise in Primary Progressive Aphasia (HEPPA) (HEPPA)

Neurodegenerative Diseases | Primary Progressive Aphasia | Semantic Dementia | Logopenic Progressive Aphasia | Non-fluent Aphasia

Canada
Montreal Heart Institute

Completed

The Cognitive and spOrt Virtual EPIC Training Study for Cardiovascular Diseases (COVEPICARDIO)

Cardiovascular Diseases

Canada
Montreal Heart Institute

Completed

PET-FDG in Myocarditis (PETMYO)

Myocarditis | Viral Myocarditis

Canada
Montreal Heart Institute

Terminated

Colchicine in HFpEF (COLpEF)

Heart Failure | Inflammation | Colchicine

Canada
Montreal Heart Institute

Terminated

Cognition and Exercise Training (COGNEX-2)

Metabolic Syndrome | Coronary Heart Disease | Chronic Heart Failure

Canada
Montreal Heart Institute

Completed

Periodization of Exercise Training in Patients With Coronary Heart Disease. (PERIOD)

Coronary Heart Disease | Healthy Control

Canada
Montreal Heart Institute

Completed

Hemodynamic Effects of Dry Sauna Followed by Cold Water Immersion in Healthy Subjects

Blood Pressure | Arrhythmias

Canada
German Heart Institute

Completed

Cardiac Magnetic Resonance Tomography for Heart Failure With Preserved Ejection Fraction

Heart Failure, Diastolic

Germany
Montreal Heart Institute

Completed

Correlation Between Coronary and Carotid Atherosclerotic Disease and Links With Clinical Outcomes

Vascular Disease

United States, Canada, Poland, Germany, Switzerland
Montreal Heart Institute

Completed

Colchicine Cardiovascular Outcomes Trial (COLCOT) (COLCOT)

Myocardial Infarction | Coronary Artery Disease

Canada
Montreal Heart Institute

Completed

Primary Reperfusion Secondary Stenting Trial (PRIMACY)

ST-elevation Myocardial Infarction

France, Canada
Montreal Heart Institute

Completed

Canadian Alliance for Healthy Hearts and Minds

Cardiovascular Diseases

Canada
Montreal Heart Institute

Completed

Colchicine in Vascular Inflammation Assessed With PET Imaging (COLPET)

Atherosclerotic Vascular Disease

Canada
InCor Heart Institute

Completed

Evaluation of Exercise Capacity and Exercise Limitation in Patients With Pulmonary Langerhans Cell Histiocytosis

Langerhans Cell Histiocytosis

Brazil
Montreal Heart Institute

Completed

Brain, Cardiac Hemodynamics and Cognition During Exercise in Subjects With Various Cardiovascular Profiles (COGNEX)

Coronary Artery Disease | Heart Failure | Metabolic Syndrome
German Heart Institute

Unknown

SMART - Systems Medicine of Heart Failure

Aortic Valve Disease

Germany
Odessa Heart Institute

Completed

Simplified Anti-Thrombotic Therapy for FFR (SMART-FFR)

Coronary Artery Disease

Clinical Trials Sponsored by Sakakibara Heart Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations